Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 58.05% |
| 2 | Technology | 7.69% |
| 3 | Financials | 6.83% |
| 4 | Healthcare | 6.42% |
| 5 | Industrials | 4.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
RXRA
1901
DELISTED
RXR Acquisition Corp. Class A Common Stock
RXRA
| $11M | 0.01% |
1,135,304
+86,862
| +8% | +$847K |
|
1902
Marriott International
MAR
$92.3B
| $11M | 0.01% |
74,495
+24,597
| +49% | +$3.43M |
|
|
PXD
1903
DELISTED
Pioneer Natural Resource Co.
PXD
| $11M | 0.01% |
66,177
-542,239
| -89% | -$82M |
|
1904
Dave Inc
DAVE
$4.77B
| $11M | 0.01% |
34,743
-1,481
| -4% | -$469K |
|
1905
Materion
MTRN
$5.13B
| $11M | 0.01% |
160,495
+31,391
| +24% | +$2.25M |
|
1906
ScottsMiracle-Gro
SMG
$3.53B
| $11M | 0.01% |
75,248
-198,935
| -73% | -$32.6M |
|
1907
Zai Lab
ZLAB
$3.01B
| $11M | 0.01% |
104,471
+30,149
| +41% | +$4.33M |
|
1908
CALL
Becton Dickinson
BDX
$51.2B
| $11M | 0.01% |
45,818
-66,625
| -59% | -$16.3M |
|
|
FMIV
1909
DELISTED
Forum Merger IV Corporation Class A Common stock
FMIV
| $11M | 0.01% |
1,125,000
+875,000
| +350% | +$8.51M |
|
|
SMIH
1910
DELISTED
Summit Healthcare Acquisition Corp. Class A Ordinary Share
SMIH
| $11M | 0.01% |
+1,125,008
| New | +$10.8M |
|
1911
Costco
COST
$415B
| $10.9M | 0.01% |
24,278
+19,095
| +368% | +$8.39M |
|
1912
SFL Corp
SFL
$1.64B
| $10.9M | 0.01% |
1,301,801
-55,100
| -4% | -$417K |
|
|
ACRO.U
1913
DELISTED
Acropolis Infrastructure Acquisition Corp Units
ACRO.U
| $10.9M | 0.01% |
+1,092,177
| New | +$10.9M |
|
|
ARBG
1914
DELISTED
Aequi Acquisition Corp
ARBG
| $10.9M | 0.01% |
1,117,389
-1
| -0% | -$10 |
|
|
SPR
1915
DELISTED
Spirit AeroSystems
SPR
| $10.9M | 0.01% |
246,261
-392,326
| -61% | -$16.4M |
|
|
TBSA
1916
DELISTED
TB SA Acquisition Corp Class A Ordinary Share
TBSA
| $10.9M | 0.01% |
1,113,643
+849,624
| +322% | +$8.2M |
|
1917
SPS Commerce
SPSC
$3.03B
| $10.9M | 0.01% |
67,358
-128,021
| -66% | -$15.8M |
|
1918
MaxLinear
MXL
$5.75B
| $10.9M | 0.01% |
220,514
+137,227
| +165% | +$6.64M |
|
|
CELL
1919
DELISTED
PhenomeX Inc. Common Stock
CELL
| $10.9M | 0.01% |
555,198
+487,092
| +715% | +$18.5M |
|
|
ONEM
1920
DELISTED
1Life Healthcare
ONEM
| $10.9M | 0.01% |
536,059
-245,800
| -31% | -$6.32M |
|
1921
Veeva Systems
VEEV
$45.8B
| $10.9M | 0.01% |
37,655
+28,777
| +324% | +$9.13M |
|
|
CND
1922
DELISTED
Concord Acquisition Corp.
CND
| $10.9M | 0.01% |
1,076,443
+1,043,753
| +3,193% | +$10.7M |
|
|
FISV
1923
CALL
Fiserv Inc
FISV
$28B
| $10.8M | 0.01% |
100,000
| – | – |
|
|
TELL
1924
DELISTED
Tellurian Inc.
TELL
| $10.8M | 0.01% |
2,768,221
-3,092,936
| -53% | -$10.6M |
|
|
MSDAU
1925
DELISTED
MSD Acquisition Corp. Unit
MSDAU
| $10.8M | 0.01% |
1,080,102
-764,580
| -41% | -$7.68M |
|
Similar funds
Israel Englander's Q3 2021 Portfolio in Review
As of Q3 2021, Israel Englander held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Israel Englander's Q3 2021 filing shows 1,245 new, 2,719 increased, 2,446 reduced and 981 closed positions. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M. The largest sale was Alexion Pharmaceuticals, an estimated $887M.
By sector, the portfolio is most concentrated in Miscellaneous at 58% of assets, up from 55% a quarter earlier, followed by Technology and Financials.
- Israel Englander's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Israel Englander's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Israel Englander fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Israel Englander's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Israel Englander opened 1,245 new positions and closed 981 in Q3 2021.
- Israel Englander's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.